This article was originally published on TipRanks.com.
This article was originally published on TipRanks.com Shares of Gilead Sciences, Inc.
This article was originally published on TipRanks.com Gilead Sciences (NASDAQ: GILD) announced on Friday that it was granted expedited approval by the U.
This article was originally published on TipRanks.com Gilead Sciences, Inc.
This article was originally published on TipRanks.com California-based Gilead Sciences (GILD) is a global biopharmaceutical company focused on developing treatments for cancers and …
Gilead Sciences, Inc. (GILD) revealed that it has been granted marketing authorization by the European Commission for Trodelvy, the company’s treatment drug for …
Shares of Gilead Sciences, Inc. (GILD) closed 1.
Shares of California-based biopharmaceutical company Gilead Sciences, Inc. (GILD) slipped 2.
Gilead Sciences’ (GILD) Kite Pharma reported follow-up data from the Zuma-5 trial of Yescarta in follicular lymphoma (FL). After a minimum period of …
Gilead Sciences (GILD) has received approval from the U.S.